Wednesday, October 26, 2016 8:17:26 AM
OGXI - .3705 Pre-market already up to .45/.47.
OncoGenex Pharmaceuticals Reveals Positive Results from Trial Study for Patients with Metastatic Bladder Cancer
OncoGenex Pharmaceuticals Reveals Positive Results from Trial Study for Patients with Metastatic Bladder Cancer
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
